. Author manuscript; available in PMC: 2010 Feb 23.

Published in final edited form as: Arch Intern Med. 2009 Feb 23;169(4):335–341. doi: 10.1001/archinternmed.2008.574

Table 3.

RRs and 95% CIs for Diagnosis of AMD According to Folic acid/B₆/B₁₂ Treatment Assignment

Endpoint	Folic acid/B₆/B₁₂ (N=2,607)	Placebo (N=2,598)	RR^*	(95% CI)	P-value
Total AMD	55	82	0.66	0.47–0.93	0.02
Visually significant AMD	26	44	0.59	0.36–0.95	0.03

Abbreviations: AMD, age-related macular degeneration; RR, relative risk; CI, confidence interval.

Adjusted for age and vitamin C, vitamin E, and beta carotene treatment assignment.